Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing the validity of cost-effectiveness models.

C McCabe1, S Dixon

  • 1Sheffield Health Economics Group, School of Health and Related Research, University of Sheffield, England. c.mccabe@sheffield.ac.uk

Pharmacoeconomics
|September 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prototype differential atom interferometer for fundamental physics.

Nature·2026
Same author

CT and MRI activity in England: insights from the diagnostic imaging dataset.

Clinical radiology·2025
Same author

Recommended conventions for reporting results from direct dark matter searches.

The European physical journal. C, Particles and fields·2025
Same author

Anaesthesia for caesarean delivery in women with class 3 obesity: a retrospective cohort study from the north-west of England (2022-2023).

International journal of obstetric anesthesia·2025
Same author

Healthcare professionals' knowledge, understanding and confidence to manage chronic pain after cancer treatment: A UK survey.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2024
Same author

Female cricket pace bowling: kinematic and anthropometric relationships with ball release speed.

South African journal of sports medicine·2024
Same journal

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

PharmacoEconomics·2026
Same journal

Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

PharmacoEconomics·2026
Same journal

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same journal

A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

PharmacoEconomics·2026
Same journal

Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

PharmacoEconomics·2026
Same journal

Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.

PharmacoEconomics·2026
See all related articles

Assessing cost-effectiveness models is challenging due to issues with economic evaluations and model construction. This study proposes a framework for quality assessment, emphasizing best practice guidelines over objective validity tests.

Area of Science:

  • Health economics
  • Decision science

Background:

  • Economic evaluations alongside controlled trials face validity challenges.
  • Cost-effectiveness models are questioned for their construction methods.

Purpose of the Study:

  • Investigate objective measurement of cost-effectiveness model quality.
  • Develop a framework for assessing model quality.

Main Methods:

  • Literature review on model quality assessment.
  • Development of a four-part framework: model structure, inputs, results, and decision-maker value.
  • Analysis of the feasibility and desirability of objective validity tests.

Main Results:

  • Significant confusion exists regarding the assessment of model quality aspects.

Related Experiment Videos

  • A framework for quality assessment is proposed, covering structure, inputs, results, and value.
  • Doubt is cast on the possibility or desirability of objective validity tests for models.

    • Conclusions:

    • Objective validity tests for cost-effectiveness models are unlikely and potentially undesirable.
    • Emphasis should shift to broader evaluation processes and good practice guidelines.
    • Quality assurance is best implemented through clear guidelines for model development and review.